Birdwood Therapeutics

Birdwood Therapeutics is a biotechnology company building AI foundation models for molecular design, trained on high-throughput kinetic measurements across up to one million binders simultaneously. Its proprietary discovery platform combines DNA-encoded scaffolds for programmable molecular diversity with biophysical AI models that learn the physics of molecular recognition, enabling predictive design of small molecules, peptides, and oligonucleotides. The company applies this platform to binder discovery, kinetic profiling, and next-generation induced proximity medicines including degraders, stabilizers, and activators.